Sjs Investment Consulting Inc. Harrow Health, Inc. Transaction History
Sjs Investment Consulting Inc.
- $540 Million
- Q4 2024
A detailed history of Sjs Investment Consulting Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 3,073 shares of HROW stock, worth $93,787. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,073
Previous 3,073
-0.0%
Holding current value
$93,787
Previous $138,000
25.36%
% of portfolio
0.02%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
174Shares Held
21.3MCall Options Held
844KPut Options Held
698K-
Opaleye Management Inc. Boston, MA3.99MShares$122 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$66 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$65.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$57 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$22.3 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $826M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...